{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:15:18Z","timestamp":1790118918141,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Bari Aldo Moro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose\/methods<\/jats:title>\n                <jats:p>Prader\u2013Willi syndrome (PWS) is a rare genetic disorder displaying different clinical features, including obesity and bone impairment. LIGHT\/TNFSF14 is a cytokine produced by immune cells affecting both fat and bone metabolism. The present study aimed to evaluate LIGHT serum levels in 28 children and 52 adult PWS patients compared to age and sex-matched controls, as well as correlations with parameters of bone and fat metabolism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median serum LIGHT levels were significantly increased in pediatric PWS with respect to controls [255.82 (284.43)\u2009pg\/ml vs 168.11 (76.23)\u2009pg\/ml, <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.02] as well as in adult PWS compared to controls [296.85 (895.95)\u2009pg\/ml vs 134.18 (141.18)\u2009pg\/ml, <jats:italic>p<\/jats:italic>\u2009\u2264\u20090.001]. In pediatric PWS, LIGHT levels were positively correlated with weight-SDS, height-SDS, and glucose levels, and negatively with total 25 (OH) vitamin D, cholesterol, LDL cholesterol and triglycerides. Additionally, LIGHT levels were negatively correlated with total BMD and fat mass. In adult PWS, LIGHT levels were positively correlated with weight, HDL cholesterol and PTH, and negatively with glucose, insulin, HOMA-IR, total cholesterol, LDL cholesterol, triglycerides, calcium, phosphorus, 25(OH)Vitamin D as well as with instrumental parameters of bone and fat quality. Consistently, multiple regression analysis showed that LIGHT serum levels in pediatric and adult PWS were predicted by different parameters including 25 (OH) Vitamin D as well as DXA parameters of bone and fat quality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In PWS children and adults the high levels of LIGHT could represent a marker of the altered bone and fat metabolism.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-023-02050-2","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:59:45Z","timestamp":1679871585000},"page":"1901-1909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["High levels of LIGHT\/TNFSF14 in patients with Prader\u2013Willi syndrome"],"prefix":"10.1007","volume":"46","author":[{"given":"M. F.","family":"Faienza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-1432","authenticated-orcid":false,"given":"G.","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fintini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grugni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Wasniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Crin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Piacente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Oranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dicarlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Colucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Grano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"2050_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jpeds.2004.01.056","volume":"144","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Kristensen K, Bruun JM, Ostergaard JR, Heickendorff L, Mosekilde L, Richelsen B (2004) Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index\u2013a cross-sectional study. J Pediatr 144:614\u2013619. https:\/\/doi.org\/10.1016\/j.jpeds.2004.01.056","journal-title":"J Pediatr"},{"key":"2050_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","volume":"38","author":"MA Angulo","year":"2015","unstructured":"Angulo MA, Butler MG, Cataletto ME (2015) Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 38:1249\u20131263. https:\/\/doi.org\/10.1007\/s40618-015-0312-9","journal-title":"J Endocrinol Invest"},{"key":"2050_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ajmg.1556","volume":"103","author":"MG Butler","year":"2001","unstructured":"Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID (2001) Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet 103:216\u2013222","journal-title":"Am J Med Genet"},{"key":"2050_CR4","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1210\/jcem.87.8.8735","volume":"87","author":"C Hoybye","year":"2002","unstructured":"Hoybye C, Hilding A, Jacobsson H, Thoren M (2002) Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. J Clin Endocrinol Metab 87:3590\u20133597. https:\/\/doi.org\/10.1210\/jcem.87.8.8735","journal-title":"J Clin Endocrinol Metab"},{"key":"2050_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00223-017-0376-y","volume":"102","author":"G Brunetti","year":"2018","unstructured":"Brunetti G, Grugni G, Piacente L, Delvecchio M, Ventura A, Giordano P, Grano M, D\u2019Amato G, Laforgia D, Crino A, Faienza MF (2018) Analysis of circulating mediators of bone remodeling in Prader-Willi syndrome. Calcif Tissue Int 102:635\u2013643. https:\/\/doi.org\/10.1007\/s00223-017-0376-y","journal-title":"Calcif Tissue Int"},{"key":"2050_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13633-018-0055-4","volume":"2018","author":"IC van Nieuwpoort","year":"2018","unstructured":"van Nieuwpoort IC, Twisk JWR, Curfs LMG, Lips P, Drent ML (2018) Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome. Int J Pediatr Endocrinol 2018:1. https:\/\/doi.org\/10.1186\/s13633-018-0055-4","journal-title":"Int J Pediatr Endocrinol"},{"key":"2050_CR7","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1210\/jc.2013-2012","volume":"98","author":"NE Bakker","year":"2013","unstructured":"Bakker NE, Kuppens RJ, Siemensma EP, Van van Wijngaarden RFTL, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Schroor EJ, Van Alfen AA, Van Leeuwen M, Van Pinxteren-Nagler E, Van Wieringen H, Vreuls RC, Zwaveling-Soonawala N, de Ridder MA, Hokken-Koelega AC (2013) Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab 98:4013\u20134022. https:\/\/doi.org\/10.1210\/jc.2013-2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2050_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092583","author":"P Marzullo","year":"2020","unstructured":"Marzullo P, Mele C, Minocci A, Mai S, Scacchi M, Sartorio A, Aimaretti G, Grugni G (2020) Fat-free mass is better related to serum uric acid than metabolic homeostasis in Prader-Willi syndrome. Nutrients. https:\/\/doi.org\/10.3390\/nu12092583","journal-title":"Nutrients"},{"key":"2050_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ajmg.a.31507","volume":"143A","author":"MG Butler","year":"2007","unstructured":"Butler MG, Theodoro MF, Bittel DC, Donnelly JE (2007) Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet A 143A:449\u2013459","journal-title":"Am J Med Genet A"},{"key":"2050_CR10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1515\/jpem-2021-0749","volume":"35","author":"M Kawai","year":"2022","unstructured":"Kawai M, Etani Y, Ida S (2022) Subcutaneous adipose tissue is a positive predictor for bone mineral density in prepubertal children with Prader-Willi syndrome independent of lean mass. J Pediatr Endocrinol Metab 35:603\u2013609. https:\/\/doi.org\/10.1515\/jpem-2021-0749","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2050_CR11","doi-asserted-by":"publisher","first-page":"12157","DOI":"10.1073\/pnas.1516622112","volume":"112","author":"G Colaianni","year":"2015","unstructured":"Colaianni G, Cuscito C, Mongelli T, Pignataro P, Buccoliero C, Liu P, Lu P, Sartini L, Di Comite M, Mori G, Di Benedetto A, Brunetti G, Yuen T, Sun L, Reseland JE, Colucci S, New MI, Zaidi M, Cinti S, Grano M (2015) The myokine irisin increases cortical bone mass. Proc Natl Acad Sci USA 112:12157\u201312162. https:\/\/doi.org\/10.1073\/pnas.1516622112","journal-title":"Proc Natl Acad Sci USA"},{"key":"2050_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostrom","year":"2012","unstructured":"Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463\u2013468. https:\/\/doi.org\/10.1038\/nature10777","journal-title":"Nature"},{"key":"2050_CR13","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s40618-021-01533-4","volume":"44","author":"MF Faienza","year":"2021","unstructured":"Faienza MF, Brunetti G, Grugni G, Fintini D, Convertino A, Pignataro P, Crino A, Colucci S, Grano M (2021) The genetic background and vitamin D supplementation can affect irisin levels in Prader-Willi syndrome. J Endocrinol Invest 44:2261\u20132271. https:\/\/doi.org\/10.1007\/s40618-021-01533-4","journal-title":"J Endocrinol Invest"},{"key":"2050_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2017.12.025","volume":"172","author":"YS Lee","year":"2018","unstructured":"Lee YS, Wollam J, Olefsky JM (2018) An integrated view of immunometabolism. Cell 172:22\u201340. https:\/\/doi.org\/10.1016\/j.cell.2017.12.025","journal-title":"Cell"},{"key":"2050_CR15","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/jbmr.3345","volume":"33","author":"G Brunetti","year":"2018","unstructured":"Brunetti G, Faienza MF, Colaianni G, Gigante I, Oranger A, Pignataro P, Ingravallo G, Di Benedetto A, Bortolotti S, Di Comite M, Storlino G, Lippo L, Ward-Kavanagh L, Mori G, Reseland JE, Passeri G, Schipani E, Tamada K, Ware CF, Colucci S, Grano M (2018) Impairment of bone remodeling in LIGHT\/TNFSF14-deficient mice. J Bone Miner Res 33:704\u2013719. https:\/\/doi.org\/10.1002\/jbmr.3345","journal-title":"J Bone Miner Res"},{"key":"2050_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134739","author":"G Brunetti","year":"2020","unstructured":"Brunetti G, Faienza MF, Piacente L, Storlino G, Oranger A, D\u2019Amato G, De Filippo G, Colucci S, Grano M (2020) Shedding \u201cLIGHT\u201d on the link between bone and fat in obese children and adolescents. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21134739","journal-title":"Int J Mol Sci"},{"key":"2050_CR17","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/oby.20524","volume":"22","author":"P Dandona","year":"2014","unstructured":"Dandona P, Ghanim H, Monte SV, Caruana JA, Green K, Abuaysheh S, Lohano T, Schentag J, Dhindsa S, Chaudhuri A (2014) Increase in the mediators of asthma in obesity and obesity with type 2 diabetes: reduction with weight loss. Obesity (Silver Spring) 22:356\u2013362. https:\/\/doi.org\/10.1002\/oby.20524","journal-title":"Obesity (Silver Spring)"},{"key":"2050_CR18","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3389\/fimmu.2018.02459","volume":"9","author":"G Brunetti","year":"2018","unstructured":"Brunetti G, Rizzi R, Storlino G, Bortolotti S, Colaianni G, Sanesi L, Lippo L, Faienza MF, Mestice A, Curci P, Specchia G, Grano M, Colucci S (2018) LIGHT\/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens. Front Immunol 9:2459. https:\/\/doi.org\/10.3389\/fimmu.2018.02459","journal-title":"Front Immunol"},{"key":"2050_CR19","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/path.5385","volume":"250","author":"G Brunetti","year":"2020","unstructured":"Brunetti G, Storlino G, Oranger A, Colaianni G, Faienza MF, Ingravallo G, Di Comite M, Reseland JE, Celi M, Tarantino U, Passeri G, Ware CF, Grano M, Colucci S (2020) LIGHT\/TNFSF14 regulates estrogen deficiency-induced bone loss. J Pathol 250:440\u2013451. https:\/\/doi.org\/10.1002\/path.5385","journal-title":"J Pathol"},{"key":"2050_CR20","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jbmr.3942","volume":"35","author":"G Brunetti","year":"2020","unstructured":"Brunetti G, Belisario DC, Bortolotti S, Storlino G, Colaianni G, Faienza MF, Sanesi L, Alliod V, Buffoni L, Centini E, Voena C, Pulito R, Novello S, Ingravallo G, Rizzi R, Mori G, Reseland JE, Ware CF, Colucci S, Ferracini R, Grano M, Roato I (2020) LIGHT\/TNFSF14 promotes osteolytic bone metastases in non-small cell lung cancer patients. J Bone Miner Res 35:671\u2013680. https:\/\/doi.org\/10.1002\/jbmr.3942","journal-title":"J Bone Miner Res"},{"key":"2050_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/jcb.24369","volume":"114","author":"C Liu","year":"2013","unstructured":"Liu C, Ding H, Zhu W, Jiang S, Xu J, Zou GM (2013) LIGHT regulates the adipogenic differentiation of mesenchymal stem cells. J Cell Biochem 114:346\u2013353. https:\/\/doi.org\/10.1002\/jcb.24369","journal-title":"J Cell Biochem"},{"key":"2050_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ijo.2010.126","volume":"35","author":"G Tiller","year":"2011","unstructured":"Tiller G, Laumen H, Fischer-Posovszky P, Finck A, Skurk T, Keuper M, Brinkmann U, Wabitsch M, Link D, Hauner H (2011) LIGHT (TNFSF14) inhibits adipose differentiation without affecting adipocyte metabolism. Int J Obes (Lond) 35:208\u2013216. https:\/\/doi.org\/10.1038\/ijo.2010.126","journal-title":"Int J Obes (Lond)"},{"key":"2050_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/eje.1.01967","volume":"153","author":"G Corneli","year":"2005","unstructured":"Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G, Ghigo E, Camanni F, Aimaretti G (2005) The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 153:257\u2013264. https:\/\/doi.org\/10.1530\/eje.1.01967","journal-title":"Eur J Endocrinol"},{"key":"2050_CR24","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240\u20131243. https:\/\/doi.org\/10.1136\/bmj.320.7244.1240","journal-title":"BMJ"},{"key":"2050_CR25","unstructured":"Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data 314:1\u201327"},{"key":"2050_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170\u2013179. https:\/\/doi.org\/10.1136\/adc.51.3.170","journal-title":"Arch Dis Child"},{"key":"2050_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1034\/j.1399-5448.2003.t01-1-00022.x","volume":"4","author":"WS Cutfield","year":"2003","unstructured":"Cutfield WS, Jefferies CA, Jackson WE, Robinson EM, Hofman PL (2003) Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children. Pediatr Diabetes 4:119\u2013125. https:\/\/doi.org\/10.1034\/j.1399-5448.2003.t01-1-00022.x","journal-title":"Pediatr Diabetes"},{"key":"2050_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/jbmr.5650070204","volume":"7","author":"DR Carter","year":"1992","unstructured":"Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137\u2013145. https:\/\/doi.org\/10.1002\/jbmr.5650070204","journal-title":"J Bone Miner Res"},{"key":"2050_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jbmr.2935","volume":"32","author":"NJ Crabtree","year":"2017","unstructured":"Team AS, Crabtree NJ, Shaw NJ, Bishop NJ, Adams JE, Mughal MZ, Arundel P, Fewtrell MS, Ahmed SF, Treadgold LA, Hogler W, Bebbington NA, Ward KA (2017) Amalgamated reference data for size-adjusted bone densitometry measurements in 3598 children and young adults-the ALPHABET Study. J Bone Miner Res 32:172\u2013180. https:\/\/doi.org\/10.1002\/jbmr.2935","journal-title":"J Bone Miner Res"},{"key":"2050_CR30","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1007\/BF03347097","volume":"34","author":"D Fintini","year":"2011","unstructured":"Fintini D, Brufani C, Grossi A, Ubertini G, Fiori R, Pecorelli L, Calzolari A, Cappa M (2011) Gender differences in bone mineral density in obese children during pubertal development. J Endocrinol Invest 34:e86-91. https:\/\/doi.org\/10.1007\/BF03347097","journal-title":"J Endocrinol Invest"},{"key":"2050_CR31","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/art.21821","volume":"54","author":"JR Edwards","year":"2006","unstructured":"Edwards JR, Sun SG, Locklin R, Shipman CM, Adamopoulos IE, Athanasou NA, Sabokbar A (2006) LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis. Arthritis Rheum 54:1451\u20131462. https:\/\/doi.org\/10.1002\/art.21821","journal-title":"Arthritis Rheum"},{"key":"2050_CR32","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1096\/fj.201800792R","volume":"33","author":"Y Kou","year":"2019","unstructured":"Kou Y, Liu Q, Liu W, Sun H, Liang M, Kong F, Zhang B, Wei Y, Liu Z, Wang Y (2019) LIGHT\/TNFSF14 signaling attenuates beige fat biogenesis. FASEB J 33:1595\u20131604. https:\/\/doi.org\/10.1096\/fj.201800792R","journal-title":"FASEB J"},{"key":"2050_CR33","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.febslet.2011.01.011","volume":"585","author":"HM Kim","year":"2011","unstructured":"Kim HM, Jeong CS, Choi HS, Kawada T, Yu R (2011) LIGHT\/TNFSF14 enhances adipose tissue inflammatory responses through its interaction with HVEM. FEBS Lett 585:579\u2013584. https:\/\/doi.org\/10.1016\/j.febslet.2011.01.011","journal-title":"FEBS Lett"},{"key":"2050_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/imcb.1002","volume":"96","author":"BM Saunders","year":"2018","unstructured":"Saunders BM, Rudnicka C, Filipovska A, Davies S, Ward N, Hricova J, Schlaich MP, Matthews VB (2018) Shining light on the metabolic role of the cytokine TNFSF14 and the implications on hepatic IL-6 production. Immunol Cell Biol 96:41\u201353. https:\/\/doi.org\/10.1111\/imcb.1002","journal-title":"Immunol Cell Biol"},{"key":"2050_CR35","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00125-019-4962-6","volume":"62","author":"A Herrero-Cervera","year":"2019","unstructured":"Herrero-Cervera A, Vinue A, Burks DJ, Gonzalez-Navarro H (2019) Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis. Diabetologia 62:2143\u20132157. https:\/\/doi.org\/10.1007\/s00125-019-4962-6","journal-title":"Diabetologia"},{"key":"2050_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13023-022-02344-3","volume":"17","author":"Y Qian","year":"2022","unstructured":"Qian Y, Xia F, Zuo Y, Zhong M, Yang L, Jiang Y, Zou C (2022) Do patients with Prader-Willi syndrome have favorable glucose metabolism? Orphanet J Rare Dis 17:187. https:\/\/doi.org\/10.1186\/s13023-022-02344-3","journal-title":"Orphanet J Rare Dis"},{"key":"2050_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2147\/DMSO.S141352","volume":"11","author":"A Crino","year":"2018","unstructured":"Crino A, Fintini D, Bocchini S, Grugni G (2018) Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes 11:579\u2013593. https:\/\/doi.org\/10.2147\/DMSO.S141352","journal-title":"Diabetes Metab Syndr Obes"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02050-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T06:23:55Z","timestamp":1690439035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02050-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02050-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The clinical investigations were in accordance with the ethical standards of the Helsinki Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the subjects before any clinical procedures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}